Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Another one I am glad I got out of. Saw the writing on the wall. Wish I was as smart with a few others. Hope everyone exits ok on this one
I hope they throw the book at these scumbags!
C. The REMSleep Holdings, Inc. (“RMSL”) Stock Promotion Scheme
102. On December 13, 2019, Costello acquired over 4.5 million shares of RMSL, and its stock closed at $0.02 that day. Costello purchased an additional 121,000 shares of RMSL on the morning of December 16.
103. Also on the morning of December 16, Costello messaged Ferraro to share his position: “RMSL. In for 4 mil total.” Ferraro replied that he would “start researching for noon so I have a story to tell.”
104. At 10:57 a.m. on December 16, Ferraro tweeted: “T minus 1 hour and 4 minutes....”
105. At noon, referencing a predicted 1,000 percent gain, Ferraro tweeted: “And the huge 10 bagger is....... $RMSL !!!!!!!!!!!!!!!!!!!!!!! $RMSL has entered the VERY LUCRATIVE Sleep apnea medical device market!!! They put out PR’s regularly. They should have a market cap over $10M!!! The chart is screaming for a massive run up!!!!”
106. Ferraro ultimately posted at least 100 tweets on December 16 and over 200 additional tweets over the next two weeks promoting RMSL. RMSL’s stock price reached an intraday high of $0.0368 on December 16 and closed at $0.031 that day, a 55 percent increase over the prior day’s close.
107. At no point did Costello or Ferraro disclose that Costello was selling RMSL stocks during this time period or that Ferraro would receive a share of Costello’s profits.
108. Costello began selling his shares of RMSL shortly after Ferraro began tweeting about RMSL on December 16, and sold his entire position by December 19 for profits of approximately $64,000. Costello shared $9,100 of those profits with Ferraro.
https://www.sec.gov/litigation/complaints/2022/comp-pr2022-178.pdf
Posters claiming DeltaWave is the first mask to-treat-COPD-which-is-false. DeltaWave is not cleared in any capacity by the FDA and certainly not specifically to treat COPD and congestive heart failure. Any FDA cleared mask can and have already been be used by people with COPD. There is NO info from RMSL claiming DeltaWave is the first mask to treat COPD or congestive heart failure.
RMSL PR generally referencing that cpaps can be used to improve these issues:
https://www.globenewswire.com/en/news-release/2020/05/04/2026575/0/en/REMSleep-Flagship-Product-Deltawave-CPAP-Interface.html
Big EOD lift today!Hmm,is news forthcoming?
Need $2millionRevenues/Quarter to break even. S-1 will be-re-filed-within-a-year.
Yes but the gross margin on those machines is only 25% and they are burning through 1/2 million in cash per quarter for operating expenses. Costs are going to go up with the additional testing required and the hiring of Judy for the new classification.
Not sustainable without dilution at some point.
Did you forget about the 1.2 million in inventory. Company had just purchased a lot of CPAP machines to sell.
Accumulated deficit increased by $440k from $10.7 million to $11.15 million.
Won't be too long before that S1 is re-filed.
Blew through $1.6-million-cash, only $120k in revenues in-2Q.
https://www.otcmarkets.com/filing/html?id=16032216&guid=Ge1-kpE91wRYzch
Link to DeltaWave new patent application #17/215,589, continuation-of-15/595,990 (now Pat No. 10,987,481)
https://patentimages.storage.googleapis.com/97/3d/f3/4a0b59464b7510/US20210213229A1.pdf
It's awful quiet in here.The calm before the storm.The last mile
It's been someone else's "fault" for seven years.
This company has been knocked down through no fault of their own,but because the FDA decided to change definitions at the last minute wow.I'm confident that this company gets approval this Fall.
11 MILLION NEGATIVE EQUITY, ZERO REVENUES
No DELTAWAVE 510k Clearance=NO ORIGINAL PRODUCT.
It’s funny you don’t mention it being up 200% from when I first started posting about RMSL in the $.0070 range…
Try and fit whatever agenda you have but the facts remain the same. SP is climbing with higher lows and real progress.
Debt free, real product, real patent, real revenues.
Not sure what the dumping was about today.
Now what's your excuse for not hitting .10?
Very bad management. Why did they come out last week and deny the QB listing when the QB listing happened this week. Without that Press Release the price would have been close to 0.1$ this week..IMO.
These guys aren't uplifting to qb because they think they're gunna fail
CEO is obligated to make material disclosures to shareholders. CEO has not disclosed that there is a pending patent application that he filed which continues the patent application on the rejected claims.
This has been discussed this ad nauseam if you take the time to read the posts which provide all the PRs, tweets, and docs from the US Patent Office relating to the events that have transpired.
Posts clearly contain documents taken directly from the US Patent Office. You can see that claims 1-6, 9-13, 15-20 are either rejected or withdrawn leaving claims 7,8, and 14 - THREE claims as the only claims approved out of 20 claims.
Three claims makes the DeltaWave so special as you asserted below?
Some of the ResMed masks have 30-40 patent claims.
You would be hard pressed to realistically believe three out of twenty claims is a solid patent.
I’m not sure I understand your assertion. They received their patent for the DeltaWave product last year (you can look it up, it’s USPTO Patent # 10,987,481). Like most patents, they made a lot of claims with the understanding that not all claims would be accepted. I checked with a friend who is a IP Attorney and he said this is common practice. Think about it - it makes total sense; there’s no harm in claiming as much as possible even if it’s unlikely they will all be accepted. All that being said, the patent as it exists FULLY protects them for the features that make the DeltaWave so special. So my question for you is the following - please clearly articulate your assertion for us. Thanks!
Post whatever nonsense you want but one thing you cannot dispute is QB status! It’s official!!!
Anyone trying to pass this off as "old news" is trying to deflect from the fact that the CEO is not transparent on material disclosures to shareholders and that the DeltaWave patent is a sham in it's current state.
ResMed wouldn't pay 5 CENTS for a shell-of-a-patent that has most of it's claims rejected/withdrawn.
New Patent Application is NEW news-#BECAUSECEOHASN'TDISCLOSEDIT.
Shareholders are under the impression that the DeltaWave is FULLY patented when that is NOT the case because MOST of the patent claims were REJECTED/WITHDRAWN.
Go through all the PRs and tweets and you will find NO DISCLOSURE to shareholders on this new patent application.
CEO tweeted 11/20/20 that he would respond to US Patent Office Action Letter aka the initial NON-FINAL patent rejection. Patent Office received his response on 12/20 and issued a FINAL REJECTION for most of the remaining claims on 1/14/21. Tom filed Hail-Mary-Pass Form AFCP 2.0 3/11/21 for rejected claims and has not issued a PR to clarify to shareholders that the bulk of the claims have been rejected and are now pending in this new application.
Are you seriously still referencing information from December 2020… since then SP is currently up over 1,500%… what are you trying to warn people about?
It appears you are trying to convince people to not make money…
Only thing Inept is your comment stating they diluted at all… ???????
Great news today!We're finding the right people to get the job done!
Tom blames Covid, testing lab, and Empirical for lack of FDA 510k clearance which has been ongoing for SEVEN YEARS - before any of those scapegoats came onto the scene.
https://www.mcapmediawire.com/remsleep-holdings-inc-engages-new-senior-director-for-regulatory-compliance-and-new-regulatory-testing-company-self-service-press-release/?utm_source=rss&utm_medium=rss&utm_campaign=remsleep-holdings-inc-engages-new-senior-di
RMSL wrecked Empirical's 100% approved record.
https://www.mcapmediawire.com/remsleep-holdings-inc-engages-new-senior-director-for-regulatory-compliance-and-new-regulatory-testing-company-self-service-press-release/?utm_source=rss&utm_medium=rss&utm_campaign=remsleep-holdings-inc-engages-new-senior-di
Old saying..."Buy on rumor, sell on news". Stinky-Pinky tickers are especially risky gambles.
What a POS dumps off news. How much did this inept management team dilute to pay Judy.
Followers
|
309
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |